Jacobs Levy Equity Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-12,776
| Closed | -$1.81M | – | 930 |
|
|
2019
Q2 | $1.81M | Sell |
12,776
-100
| -0.8% | -$14.2K | 0.03% | 542 |
|
|
2019
Q1 | $1.87M | Sell |
12,876
-49,766
| -79% | -$7.23M | 0.03% | 519 |
|
|
2018
Q4 | $7.09M | Sell |
62,642
-110
| -0.2% | -$12.5K | 0.12% | 186 |
|
|
2018
Q3 | $8.44M | Buy |
62,752
+41,922
| +201% | +$5.64M | 0.12% | 202 |
|
|
2018
Q2 | $2.34M | Buy |
20,830
+16,930
| +434% | +$1.9M | 0.04% | 474 |
|
|
2018
Q1 | $416K | Buy |
+3,900
| New | +$416K | 0.01% | 807 |
|
|
2017
Q2 | – | Sell |
-8,610
| Closed | -$774K | – | 945 |
|
|
2017
Q1 | $774K | Sell |
8,610
-33,660
| -80% | -$3.03M | 0.02% | 597 |
|
|
2016
Q4 | $3.22M | Buy |
42,270
+90
| +0.2% | +$6.86K | 0.06% | 324 |
|
|
2016
Q3 | $3.52M | Sell |
42,180
-45,830
| -52% | -$3.82M | 0.06% | 321 |
|
|
2016
Q2 | $7.26M | Sell |
88,010
-32,470
| -27% | -$2.68M | 0.15% | 191 |
|
|
2016
Q1 | $9.15M | Sell |
120,480
-19,830
| -14% | -$1.51M | 0.19% | 155 |
|
|
2015
Q4 | $11.3M | Sell |
140,310
-15,400
| -10% | -$1.24M | 0.22% | 137 |
|
|
2015
Q3 | $9.89M | Buy |
155,710
+44,060
| +39% | +$2.8M | 0.2% | 147 |
|
|
2015
Q2 | $7.85M | Buy |
111,650
+43,110
| +63% | +$3.03M | 0.15% | 175 |
|
|
2015
Q1 | $5.44M | Buy |
+68,540
| New | +$5.44M | 0.09% | 220 |
|
|
2014
Q4 | – | Sell |
-6,000
| Closed | -$358K | – | 837 |
|
|
2014
Q3 | $358K | Sell |
6,000
-11,820
| -66% | -$705K | 0.01% | 644 |
|
|
2014
Q2 | $954K | Sell |
17,820
-9,650
| -35% | -$517K | 0.02% | 521 |
|
|
2014
Q1 | $1.66M | Buy |
+27,470
| New | +$1.66M | 0.03% | 432 |
|